Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


The 340B Drug Discount Program: Why More Transparency Will Help Low-Income Communities

340B Discount Drug Program

The federal 340B Drug Pricing Program is currently a focus of oversight efforts by Congress. In a new post, the University of Chicago’s Rena M. Conti explains why greater transparency is needed for the program, which requires drug manufacturers to provide discounted outpatient drugs to qualified health care facilities serving low-income patients.

Publication Details